ライフサイエンスコーパス: -attracting

1 ls (DCs) and induced production of the T(H)2-attracting chemokines TARC (thymus and activation-regula

2 s encode a pollen tube growth-promoting and -attracting protein needed for optimal in vivo pollen tub

3 ently stimulates the expression of Th-1 cell-attracting chemokines and chemokine receptors on the ocu

4 lecules and produce the T helper type 2 cell-attracting chemokine CCL17.

5 B cell-attracting chemokine 1 (BCA-1) responses correlate with

6 CNSL to investigate the expression of B cell-attracting chemokine 1 (BCA-1, CXCL13), a lymphoid chemo

7 uctures (B-cell activating factor and B cell-attracting chemokine 1).

8 The B cell-attracting chemokine CXCL13 is an important mediator in

9 expected expression of the follicular B cell-attracting chemokine CXCL13/BCA-1, suggesting a novel fo

10 -derived factor-1/CXCL12), and CXCR5 (B cell-attracting chemokine-1/CXCL13); but not to ligands for o

11 ed associations with NHL for elevated B-cell-attracting chemokine 1 (BCA-1; fourth quartile vs first:

12 lasmacytoid dendritic cells and CCR5(+ )cell-attracting chemokines produced by these cells, in combin

13 f the invariant natural killer T (iNKT) cell-attracting chemokine MCP-1 and of the antigen-presenting

14 At least two cutaneous T cell-attracting chemokine (CTACK), three SLC, and four ELC ge

15 rization of a CC chemokine, cutaneous T cell-attracting chemokine (CTACK).

16 the keratinocyte-expressed cutaneous T cell-attracting chemokine (CTACK; CCL27), and MEC supports ch

17 Cutaneous T cell-attracting chemokine (CTACK; CCL27), expressed by skin k

18 New work showing that the T cell-attracting chemokine CCL2 can be posttranslationally mod

19 D80, CD83, CD86, IL-1, IL-12, and the T cell-attracting chemokine CCL27/CTACK) and consequently an en

20 mmunobiological properties, e.g., the T cell-attracting chemokine CCL27/CTACK, calcium-dependent prot

21 e) and neurotropic TG delivery of the T cell-attracting chemokine CXCL10 (pull), boosted the number a

22 he T cell-dependent production of the T cell-attracting chemokine macrophage inflammatory protein-1 a

23 loid cells; it induces the release of T cell-attracting chemokines from monocytes and, in particular,

24 ines were not increased and levels of T cell-attracting chemokines were decreased.

25 le to the epigenetic silencing of key T cell-attracting inflammatory chemokine genes in decidual stro

26 Importantly, TriMix mRNA induced a T-cell-attracting and stimulatory environment, including recrui

27 ction for chemoattractants: cutaneous T-cell-attracting chemokine (CTACK), thymus and activation-regu

28 emotactic responsiveness to cutaneous T-cell-attracting chemokine (CTACK)/CCL27 (a CCR10 ligand) para

29 oligomerization behavior of cutaneous T-cell-attracting chemokine (CTACK, also known as CCL27) by NMR

30 DC markers and enhanced expression of T-cell-attracting chemokine macrophage inflammatory protein 1-a

31 rived factor-1alpha, IP-10, cutaneous T-cell-attracting chemokine, monokine induced by IFN-gamma, tum

32 lated with intratumoral expression of T-cell-attracting chemokines and with T-cell infiltration.

33 ary, we have shown that monocyte- and T-cell-attracting chemokines are associated with monocyte and T

34 Th2 cell-attracting CCL7 but not of Th1 cell-attracting chemokines.

35 ction site, i.e., the expression of Th2 cell-attracting CCL7 but not of Th1 cell-attracting chemokine

36 cal for eliciting production of the TH2 cell-attracting chemokine CCL17 by IRF4(+)CD11b(+)CD103(-) de

37 to the pathogenesis of HIV in vivo by chemo-attracting activated CD4+ cells to sites of viral replic

38 broblast function through secretion of chemo-attracting agents, as well as through growth factors and

39 erleukin-12, interferon-gamma, and chemokine-attracting T cells, and they induced antigen-specific T-

40 utocrine manner to trigger the release of DC-attracting chemokines, GM-CSF, and IL-33.

41 lity of enhancing tumor production of T(eff)-attracting chemokines as a cancer therapeutic strategy u

42 o hyperactivate NF-kappaB and produce T(eff)-attracting chemokines in response to treatment, resultin

43 ation of T(eff) express low levels of T(eff)-attracting chemokines such as CXCL10/IP10 and CCL5/RANTE

44 the QSAR for the interactions of 27 electron-attracting phenols in L1210 cells, log 1/ID50 = 0.56 log

45 o0F, demonstrated the importance of electron-attracting substituents in the salicyloyl ring and hydro

46 s males, but not females, produce the female-attracting dhas#18.

47 produce high levels of the immature DC (iDC)-attracting chemokines CCL3 and CCL4 upon exposure to tum

48 fresh fruits, such as tomato, and an insect-attracting scent in roses and many other flowers.

49 a (to create an artificial gradient of an LC-attracting chemokine) and topical application of hapten

50 erferon-gamma, interleukin-2, and lymphocyte-attracting chemokines within the tumor.

51 Of the two lymphocyte-attracting chemokines assessed, monocyte-chemotactic pro

52 increased expression of a single macrophage-attracting chemokine in the context of an inflammatory m

53 elay to reduced production of the macrophage-attracting chemokine MCP-1 in the gammadelta-T-cell-knoc

54 ted with T cell production of the macrophage-attracting chemokines CCL3 and CCL4.

55 ides allowed full reconstitution of the male-attracting activity of wild-type pheromone extract.

56 vus females, but not males, produce the male-attracting ascr#1, whereas males, but not females, produ

57 ASA treatment also reduced the MDSC-attracting chemokine CCL2 (C-C motif ligand 2) in the TM

58 dle ear infection, and upregulate a monocyte-attracting chemokine through TLR2-dependent NF-kappaB ac

59 owed diminished mRNA expression for monocyte-attracting chemokines, and significantly less CXCL9 and

60 tion of Bmal1 induces expression of monocyte-attracting chemokines and disrupts rhythmic cycling of L

61 Nod2 is responsible for regulating monocyte-attracting chemokines to the inflamed gut.

62 The monocyte-attracting chemokines CXCL9, 10, and 11 were preferentia

63 9, and T helper type 17-cell- and neutrophil-attracting chemokines.

64 Depleting neutrophils or blocking neutrophil-attracting chemokines restored normal histology in lymph

65 ed chemokine, one of the dominant neutrophil-attracting chemokines in mice, further revealed an indir

66 lergen-induced release of further neutrophil-attracting chemokines, migration of DCs to the draining

67 It also increases neutrophil-attracting chemokines resulting in recruitment and activ

68 ed with increases in the level of neutrophil-attracting chemokines KC and MIP-2, known to play a role

69 L-17A to induce the expression of neutrophil-attracting chemokines.

70 tivity enhances the production of neutrophil-attracting factors and protects hyaluronic acid (HA) fro

71 increased lung production of the neutrophil-attracting chemokines CXCL-1 and CXCL-2.

72 70-modulated T cells, whereas the neutrophil-attracting chemokines CXCL1 and CXCL2 were up-regulated

73 IL-17F induced expression of the neutrophil-attracting chemokines CXCL1 and CXCL5 in kidney cells.

74 terleukin-1 (IL-1), IL-6, and the neutrophil-attracting chemokines KC, LIX, and MIP-2 was rapidly ind

75 which drive the expression of the neutrophil-attracting chemokines, are important for the clearance o

76 d that CD11b(+) DCs expressed the neutrophil-attracting cytokine CXCL2, whereas CD103(+) DCs expresse

77 atinocyte chemoattractant and the neutrophil-attracting cytokine IL-6 in corneas without HSK.

78 ocused on MIP-2 and KC/CXCL1, two neutrophil-attracting CXC chemokines.

79 rus (WNV), we found that expression of 2 PMN-attracting chemokines, Cxcl1 and Cxcl2, was rapidly and

80 ich the DNA is either self-repelling or self-attracting.

81 oocytes that synthesize prostaglandin sperm-attracting cues.

82 d chemokine (MDC)/CCL22, I-309/CCL1) and Th1-attracting (IFN-gamma-inducible protein 10 (IP-10)/CXCL1

83 (TARC/CCL17, MDC/CCL22, I-309/CCL1), and Th1-attracting (IP-10/CXCL10, I-TAC/CXCL11) chemokines in th

84 of Ip10 and Cxcl9 transcripts, encoding Th1-attracting chemokines, were significantly reduced in the

85 sion of TSLP and Th2-attracting, but not Th1-attracting, chemokines as compared with controls, with s

86 of the PGE(2)-exposed DC to secrete the Th1-attracting chemokines: CXCL9, CXCL10, CXCL11, and CCL5.

87 High levels of the Th1-attracting, HIV-1-inhibitory chemokines, CCL3/MIP-1alpha

88 expression of TSLP and the same Th1- and Th2-attracting chemokines.

89 bronchial mucosal expression of TSLP and Th2-attracting, but not Th1-attracting, chemokines as compar

90 ression and cellular provenance of TSLP, Th2-attracting (TARC/CCL17, MDC/CCL22, I-309/CCL1), and Th1-

91 ression and cellular provenance of TSLP, Th2-attracting (thymus and activation-regulated chemokine (T

92 f type I and type II IFNs, showing high Treg-attracting activity.

93 inflammation and cancer, induces stable Treg-attracting properties in maturing DC, mediated by CCL22.

94 ndings argue that type I IFN blocks the Treg-attracting chemokine CCL22 and thus helps limit the recr

95 cells in BAL and greater levels of the Treg-attracting chemokine CCL22.

96 gamete fusion fails, one of two pollen tube-attracting synergid cells persists, enabling the ovule t